Clinical Discussions in MDS

Treatment-related Adverse Effects in MDS: Managing Them Before They Derail Therapy
Treatment-related Adverse Effects in MDS: Managing Them Before They Derail Therapy
CME, CPE, CNE
Amy E. DeZern, MD, MHS
Release Date: October 31, 2016
Expiration Date: October 31, 2017

The optimization of treatment for patients with myelodysplastic syndromes (MDS) is largely dependent on the treatment-related adverse effects of therapy. Practitioners across the multidisciplinary health care provider team must be able to recognize toxicities associated with therapeutic regimens and employ the appropriate management strategies. In this activity, Dr. DeZern will present the most up-to-date information and data concerning proactive and effective management of treatment-related adverse effects in patients with MDS.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
View Only, CE ExpiredView Only, No Credit
 
The Lower-Risk Elderly MDS Patient: Clinical Challenges and Opportunities
The Lower-Risk Elderly MDS Patient: Clinical Challenges and Opportunities
CME, CPE
Mikkael A. Sekeres, MD, MS
Release Date: March 31, 2016
Expiration Date: March 31, 2017

Advances in our knowledge of genetic abnormalities associated with MDS, as well as advances in diagnosis and risk stratification, are improving the ability of community oncologists to individualize treatment to each patient’s disease. The majority of patients diagnosed with MDS are elderly, and often have potentially significant comorbidities, which often complicate the development of appropriate and effective treatment. Significant progress has been made in the treatment of MDS, however, with three drugs currently approved specifically for the treatment of this disease.

Follow Dr. Sekeres through this video presentation for an in-depth discussion and case review of an older patient with low-risk MDS. Learn how to navigate today’s current treatment paradigm and the best strategies for addressing the special needs of this patient population.

For more information on managing your patients with MDS, please view the FAQs available here.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
View Only, CE ExpiredView Only, No Credit
 

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved